Multikine cytokine mixture: CELI began a Phase I/II trial

Cel-Sci Corp. (CELI), Alexandria, Va.
Product: Multikine cytokine mixture
Indication: Squamous cell carcinoma

Read the full 130 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE